Deferoxamine,an iron chelator,is an FDA-approved drug for the treatment of acute iron intoxication and chronic iron overload due to transfusion-dependent anemia.
铁螯合剂去铁敏是经食品和药物管理局(FDA)批准的,用来治疗急性铁中毒,和由于长期输血导致的慢性铁中毒。
参考来源 - 去铁敏在脑出血治疗中的应用·2,447,543篇论文数据，部分数据来源于NoteExpress
Results Daphnetin exhibited a modest iron-chelating ability compared with the powerful iron-chelator desferrioxamine B.
结果 与强铁螯合剂去铁胺相比 ，瑞香素具有中度的铁螯合能力。
No patient has been given an iron chelator via a continuous intrathecal infusion, which might be more effective.
尽管连续鞘内注射铁鏊合剂可能更有效，但尚未见有病人经此方法治疗。
This review summarized the morbidity, mortality, and clinical features of iron overload, and introduced the advantages of the new chelator deferasirox over traditional agents.
本文就铁过载的临床特征、危害性以及祛铁新药地拉罗司对比传统药物的优势做一综述。
应用推荐